Humans and animals lose tissues and organs due to congenital defects, trauma, and
diseases. The human body has a low regenerative potential as opposed to the urodele …

Cardiovascular disease is the leading cause of death worldwide, with this trend predicted to
continue for the foreseeable future. Common disorders are associated with the stenosis or …

Current clinical treatment strategies for the bypassing of small diameter (< 6 mm) blood
vessels in the management of cardiovascular disease frequently fail due to a lack of suitable …

Cardiovascular defects, injuries, and degenerative diseases often require surgical
intervention and the use of implantable replacement material and conduits. Traditional …

Polyester elastomers are soft, biodegradable and biocompatible and are commonly used in
various biomedical applications, especially in tissue engineering. These synthetic polyesters …

Tissue engineered vascular grafts (TEVGs) are beginning to achieve clinical success and
hold promise as a source of grafting material when donor grafts are unsuitable or …

The creation of a living heart valve is a much-wanted alternative for current valve prostheses
that suffer from limited durability and thromboembolic complications. Current strategies to …

Vascular tissue engineering has made prodigious progress in recent years by converging
multidisciplinary approaches. Latest technological advancements foster the development of …

Biomaterials, traditionally defined as materials used in medical devices, have been used
since antiquity, but recently their degree of sophistication has increased significantly …

Certain polymeric materials such as polyurethanes (PUs) are the most prevalent class of
used biomaterials in regenerative medicine and have been widely explored as vascular …